In naming former medical devices VP Robert Ford as COO, Abbott said Ford oversaw the integration of St. Jude Medical and was instrumental in the debut of Abbott’s FreeStyle Libre glucose monitoring device.
“Robert is a strong leader who consistently demonstrates Abbott’s successful management philosophy and strategy, and has a successful track record of delivering business results,” chairman & CEO Miles White said in prepared remarks.
“On behalf of the Board, I want to thank Carl O’Connell for his dedication and contributions, notably guiding the company through the recent restructuring process. We wish Carl all the best,” chairman Jeff Peters said in prepared remarks. “Mike is a proven leader with over 25 years of successful business leadership in the medical technology industry. He has led businesses at both public and private medical technology companies resulting in growth, operational improvement, and enhanced shareholder value. His unique experience in the global orthopaedic and spinal markets will be particularly valuable, and we are pleased to have him in this interim role.”
The Hartmann Group named former Clariant (SIX:CLN) executive Britta Fuenfstueck to be its new CEO effective Jan. 1, 2019, replacing Andreas Joehle, who is stepping down due to personal reasons. Fuenfstueck is slated to join Hartmann’s board Nov. 1.
LuxCath said it named 30-year medical device veteran Terry Ransbury to be its chief technology officer. Ransbury was co-founder & president of Nocturnal Product Development, which helped develop LuxCath’s OmniView ablation catheter.
Private equity firm EW Healthcare Partners said it named former Smith & Nephew (NYSE:SNN) CEO Olivier Bohuon as a senior advisor and former Abbott (NYSE:ABT) executive Mike Warmuth as an operating partner.
- Bango taps ex-Smith & Nephew exec Rand for CFO
- Varian promotes Kennedyto proton solutions president, Toth to oncology systems prez
- Vero Biotech names Gentile as medical affairs VP
- Mack Molding promotes biz dev exec Whitney
- Irras names Sampson as product excellence VP, De Cicco as product development senior director
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.